The DOI matches its Crossref record; 167 of the 167 references it cites were found in a registry or an index.
Molecular genetics of early-onset Alzheimer’s disease revisited
Open accessAbstract
As the discovery of the Alzheimer's disease (AD) genes, APP, PSEN1, and PSEN2, in families with autosomal dominant early-onset AD (EOAD), gene discovery in familial EOAD came more or less to a standstill. Only 5% of EOAD patients are carrying a pathogenic mutation in one of the AD genes or a apolipoprotein E (APOE) risk allele ε4, most of EOAD patients remain unexplained. Here, we aimed at summarizing the current knowledge of EOAD genetics and its role in ongoing approaches to understand the biology of AD and disease symptomatology as well as developing new therapeutics. Next, we explored the possible molecular mechanisms that might underlie the missing genetic etiology of EOAD and discussed how the use of massive parallel sequencing technologies triggered novel gene discoveries. To conclude, we commented on the relevance of reinvestigating EOAD patients as a means to explore potential new avenues for translational research and therapeutic discoveries.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“These rare mutations cause the aggregation of amyloid proteins, leading to the progression of early onset AD.”
From Role of neuroinflammation in neurodegeneration development (2023) · cites this paper as [157]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“But it was until 1980s that three genes, including APP, PSEN1, and PSEN2, were found to be responsible for early onset AD.157”
From Role of neuroinflammation in neurodegeneration development (2023) · cites this paper as [157]
Experimental — accuracy not yet measuredIn the citing paper
“PSEN2 mutations are much rarer, with only around 30 mutations identified in ADAD families [2].”
From Genetic architecture of Alzheimer's disease (2020) · cites this paper as [2]
In the citing paper
“A majority of ADAD families carry a pathogenic mutation in one of three genes: APP, presenilin 1 (PSEN1), or presenilin 2 (PSEN2) [2, 33].”
From Genetic architecture of Alzheimer's disease (2020) · cites this paper as [2]
In the citing paper
“To date, more than 50 highly penetrant mutations have been identified in APP [2].”
From Genetic architecture of Alzheimer's disease (2020) · cites this paper as [2]
In the citing paper
“ADAD is very rare, accounting for less than <1% of all cases of AD [2, 31–33]”
From Genetic architecture of Alzheimer's disease (2020) · cites this paper as [2]
In the citing paper
“While mutations in these genes are the most well-studied mutations associated with EOAD, it is estimated that a significant portion of EOAD remains unexplained genetically [2].”
From Genetic architecture of Alzheimer's disease (2020) · cites this paper as [2]
In the citing paper
“Gene duplications of APP are well-known to cause AD, with as many as 25 duplications of variable length associated with AD in EOAD families [2]”
From Genetic architecture of Alzheimer's disease (2020) · cites this paper as [2]
In the citing paper
“The large variability in the age at onset of AD symptoms even among families who share common pathogenic mutations [31]”
From Genetic architecture of Alzheimer's disease (2020) · cites this paper as [31]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
McKhann, G. M., Knopman, D. S., Chertkow, H., Hyman, B. T., Jack, C. R., Kawas, C. H., Klunk, W. E., Koroshetz, W. J., Manly, J. J., Mayeux, R., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.005 · Cited by 18,657
Corder, E. H., Saunders, A. M., Strittmatter, W. J., Schmechel, D. E., Gaskell, P. C., Small, G. W., Roses, A. D., Haines, J. L., & Pericak-Vance, M. A. (1993) · Science · doi:10.1126/science.8346443 · Cited by 9,429
Alzheimer's disease: the amyloid cascade hypothesis
Hardy, J. A., & Higgins, G. A. (1992) · Science · doi:10.1126/science.1566067 · Cited by 7,484
Glenner, G. G., & Wong, C. W. (1984) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(84)80190-4 · Cited by 5,404
Goate, A., Chartier-Harlin, M.-C., Mullan, M., Brown, J., Crawford, F., Fidani, L., Giuffra, L., Haynes, A., Irving, N., James, L., et al. (1991) · Nature · doi:10.1038/349704a0 · Cited by 4,659
The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor
Kang, J., Lemaire, H.-G., Unterbeck, A., Salbaum, J. M., Masters, C. L., Grzeschik, K.-H., Multhaup, G., Beyreuther, K., & Müller-Hill, B. (1987) · Nature · doi:10.1038/325733a0 · Cited by 4,619
Amyloid plaque core protein in Alzheimer disease and Down syndrome.
Masters, C. L., Simms, G., Weinman, N. A., Multhaup, G., McDonald, B. L., & Beyreuther, K. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.12.4245 · Cited by 4,431
Meta-Analysis of 74,046 Individuals Identifies 11 New Susceptibility Loci for Alzheimer’s Disease
(EADI), E. A. D. I., Lambert, J.-C., (GERAD), G. A. E. R. I. A. D., Alzheimer's Disease Genetic Consortium (ADGC), (CHARGE), C. F. H. A. A. R. I. G. E., Ibrahim-Verbaas, C. A., Harold, D., Naj, A. C., Sims, R., Bellenguez, C., et al. (2013) · Nature Genetics · doi:10.1038/ng.2802 · Cited by 4,336
Self-citationStrittmatter, W. J., Saunders, A. M., Schmechel, D., Pericak-Vance, M., Enghild, J., Salvesen, G. S., & Roses, A. D. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.5.1977 · Cited by 4,268
Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease
Sherrington, R., Rogaev, E. I., Liang, Y., Rogaeva, E. A., Levesque, G., Ikeda, M., Chi, H., Lin, C., Li, G., Holman, K., et al. (1995) · Nature · doi:10.1038/375754a0 · Cited by 4,051
Cited by
Sorted by citations
Items 501–600 of 617
Çelik, S., Russell, J. C., Pestana, C. R., Lee, T.-I., Mukherjee, S., Crane, P. K., Keene, C. D., Bobb, J. F., Kaeberlein, M. R., & Lee, S. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/302737 · Cited by 1
Cavini, Í. A. (2019) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.76.2019.tde-07052019-102916 · Cited by 1
Kotredes, K. P., Oblak, A. L., Pandey, R. S., Lin, P. B., Garceau, D. T., Williams, H. M., Uyar, A., O’Rourke, R., O’Rourke, S., Ingraham, C. M., et al. (2021) · Research Square · doi:10.21203/rs.3.rs-580913/v1 · Cited by 1
GWAS on short tandem repeats identifies novel genetic mechanisms in Alzheimer’s diseasePreprint
Gmelin, D., Ohlei, O., Aslam, M., Parkkinen, L., Mullin, K., Prokopenko, D., Lill, C. M., Tanzi, R. E., Dobričić, V., & Bertram, L. (2025) · medRxiv · doi:10.1101/2025.03.13.25323833 · Cited by 1
Vrba, S. M., Laaker, C. J., Limkar, A. R., Hsu, M., Ricke, W. A., Ulland, T. K., Pehar, M., Sándor, M., & Fábry, Z. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.05.15.654007 · Cited by 1
Strategies for Neuroprotection in Alzheimer's Disease
Jasutkar, H. G. (2025) · Wiley eBooks · doi:10.1002/9783527844678.ch5 · Cited by 1
Borgers, H. (2017) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-6363
Young, J. E., & Delgado‐Morales, R. (2018) · Springer eBooks · doi:10.1007/978-3-319-90695-9_1
A Hidden Etiological Nemesis of Chronic Neurodegenerative Diseases
Downs, B. W., & Bagchi, M. (2017) · CRC Press eBooks · doi:10.1201/9781315152998-1
Diário da Teoria e Prática na Enfermagem 3
Sombra, I. C. D. N. (2020) · doi:10.22533/at.ed.320201402
Studie zur Rolle N-trunkierter Amyloid-β-Peptide bei der Alzheimer-Krankheit
Gießen, N. M.-E. (2019) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-7657
Inherited neurodegenerative diseases
Sathe, S. A. (2020) · doi:10.1093/med/9780198746690.003.0606
Luukkainen, L., Huttula, S., Väyrynen, H., Helisalmi, S., Kytövuori, L., Haapasalo, A., Hiltunen, M., Remes, A. M., & Krüger, J. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-200069
Alzheimer’s disease pathogenesis and risk factors
Gerulytė, A., & Strumylaitė, L. (2019) · Neurologijos seminarai · doi:10.29014/ns.2019.25
Ageing in Better Mental Health
Cordella, M., & Poiani, A. (2021) · International perspectives on aging · doi:10.1007/978-3-030-60071-6_4
Jester, H. M., Gosrani, S. P., Ding, H., Zhou, X., Ko, M., & Ma, T. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.07.21.453246
Sproul, A. A. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-817876-8.00002-4
Desperation and d'sespoir: gay activism in France
Wharton, S. (1995)
Wang, Z., Zhang, Q., Lin, J.-R., Jabalameli, M. R., Mitra, J., Nguyen, N., & Zhang, Z. (2020) · doi:10.21203/rs.3.rs-96273/v1
Tsui, N. B. Y., & Lau, J. Y. N. (2021) · Springer eBooks · doi:10.1007/978-3-030-22009-9_937
Chen, C., Lin, Y., Lee, W., Liao, Y., Kuo, Y.-S., Yang, A. C., & Fuh, J. (2022) · Research Square · doi:10.21203/rs.3.rs-1348025/v1
Alzheimer’s Disease Drug Discovery in Academia: From High-Throughput Screening to In Vivo Testing
Brunden, K. R., Nzou, G., & Ballatore, C. (2022) · Cambridge University Press eBooks · doi:10.1017/9781108975759.004
Diagnosis and Epidemiology of Dementia
Kreisl, W. C., & Reitz, C. (2017) · Oxford University Press eBooks · doi:10.1093/med/9780190681425.003.0050
Chi, L. S., & Wadhwani, A. (2017) · The American Pharmacists Association eBooks · doi:10.21019/pharmacotherapyfirst.alzheimers_overview
Ashford, J. W. (2018) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.734280398.793553881
Tampi, R. R., & Tampi, D. J. (2021) · Springer eBooks · doi:10.1007/978-3-030-58663-8_10
Tsui, N. B. Y., & Lau, J. Y. N. (2019) · Springer eBooks · doi:10.1007/978-3-319-69892-2_937-1
Pathogénie et physiopathologie de la maladie d’Alzheimer
Nicole, O. (2022) · Elsevier eBooks · doi:10.1016/b978-2-294-76331-1.00002-1 · Cited by 1
Causes of Genetic Conditions and Laboratory and Testing Approaches
(2022) · Wiley eBooks · doi:10.1002/9781119847212.ch4
Gendiagnostik bei neurodegenerativen Erkrankungen
Greiten, B., Brüggemann, N., Spielmann, M., & Klein, C. (2022) · InFo Neurologie + Psychiatrie · doi:10.1007/s15005-022-2446-6
WIN-55,212-2-Therapie in einem Modell für die sporadische Alzheimer Erkrankung
Ott, F. W. (2022) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-9572
Sanhueza, M., Manso, Y., Soto, C. A., & Salvadores, N. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.1104647
Understanding the Code of Life: Holistic Conceptual Modeling of the Genome
Alberto García, S. (2022) · doi:10.4995/thesis/10251/191432
Analysis of “clinical exome” panel in Serbian patients with cognitive disorders
Branković, M., Stefanova, E. D., Mandić, G., Marjanović, A., Dobričić, V., Maver, A., Bergant, G., Stević, Z., Janković, M. Z., Novaković, I. V., et al. (2022) · Genetika · doi:10.2298/gensr2203351b
Whole-exome sequencing detected a novel APP variant in a Han-Chinese family with Alzheimer’s disease
Zhaoxia, W., Chenyu, W., ZhuangZhuang, Y., Liangliang, F., Lin, X., & Tang, T. (2023) · Molecular Biology Reports · doi:10.1007/s11033-023-08400-w
Alzheimer’s disease beyond the amyloid accumulation
Urkon, M., & Nagy, E. E. (2022) · Orvostudományi Értesítö · doi:10.2478/orvtudert-2022-0002
Eta-secretase-like processing of the amyloid precursor protein (APP) by RHBDL4Preprint
Penalva, Y. C. M., Paschkowsky, S., Recinto, S. J., Duchesne, A., Levet, C., Charron, F. M., Freeman, M., McKinney, R. A., Trempe, J., & Munter, L. M. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.09.04.555897
Mechanisms of Thai medicinal plant extracts on the attenuation of glutamate-mediated neurotoxicity
Prasansuklab, A. (2017) · Chula Digiverse · doi:10.58837/chula.the.2017.156
König, S., Schmidt, N., Bechberger, K., Morris, S., Priego, M., Zaky, H., Song, Y.-Y., Pielage, J., Brunholz, S., Brady, S. T., et al. (2023) · Cells · doi:10.3390/cells12192403
Solares, C., Zhang, L., Chang, Z., Andershed, H., Persson, J., & Larsson, H. (2023) · Innovation in Aging · doi:10.1093/geroni/igad117
Li, Y., Zhu, Y., & Yao, M. (2023) · Human Brain · doi:10.37819/hb.2.1770
Varghese, R., Digholkar, G., Deshpande, A., & Kumar, D. (2023) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9789815136142123010013 · Cited by 1
Curdt, N. (2024) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-10405
Li, Q. S., Sun, Y., & Wang, T. (2020) · Figshare · doi:10.6084/m9.figshare.13107636
Features of the clinical and neuroimaging picture in patients with early-onset Alzheimer’s disease
Коваленко, Е. А., Makhnovich, E. V., Bogolepova, A. N., Osinovskaya, N. A., & Beregov, M. M. (2024) · S S Korsakov Journal of Neurology and Psychiatry · doi:10.17116/jnevro202412404256
Sobczyk, M., Słaboń, M., Pasztelan, M., Pulikowski, J., Garbacz, K., Maciąg, M., Walczuk, J. K. V., Baran, J., Muca, A., & Marczak, A. (2024) · Journal of Education Health and Sport · doi:10.12775/jehs.2024.70.49802
Deep Learning Tactics for Neuroimaging Genomics Investigations in Alzheimer's Disease
Rajput, M. S., Shah, J., Patel, V., Rajput, N. S., & Kumar, D. (2024) · Wiley eBooks · doi:10.1002/9781394234196.ch14 · Cited by 1
Eryılmaz, I. E., Bakar, M., Egelí, Ü., & Çeçener, G. (2024) · Uludağ Üniversitesi Tıp Fakültesi Dergisi · doi:10.32708/uutfd.1468449
Коваленко, Е. А., Makhnovich, E. V., Bogolepova, A. N., Osinovskaya, N. A., & Beregov, M. M. (2024) · Neuroscience and Behavioral Physiology · doi:10.1007/s11055-024-01680-0 · Cited by 1
Alzheimer's disease: therapeutic potential of phytocannabinoids
da Silva, T. C. C., da Silva, A. R., Campagnone, C. H. D. S., Alves, A. J., & da Silva, V. A. (2024) · Concilium · doi:10.53660/clm-3910-24q30
Gerhand, S. (2024) · Cambridge University Press eBooks · doi:10.1017/9781009025911.002
Gerhand, S. (2024) · Cambridge University Press eBooks · doi:10.1017/9781009025911.006
Luo, S., Xu, X., Liu, J., Tang, B., Zhang, J. Z. H., & Duan, L. (2024) · Journal of Molecular Liquids · doi:10.1016/j.molliq.2024.126562
New Research on Biomarkers in Alzheimer’s Continuum
Vecchio, I., & Colica, C. (2025) · Reviews on Recent Clinical Trials · doi:10.2174/0115748871331138250114052615 · Cited by 2
Diagnosis and Epidemiology of Dementia
Kreisl, W. C., & Reitz, C. (2025) · Oxford University Press eBooks · doi:10.1093/med/9780197640654.003.0052
Clinical investigation cases studies and critical thinking problem approaches
ZEIDAN, H. M., & ZEIDAN, I. H. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-21632-9.00010-8
Wu, C.-T., Hu, L.-H., Weng, H., Liu, Y.-M., Lin, Y., Tsai, S., Lo, R. Y., & Ching, Y.-H. (2025) · Tzu Chi Medical Journal · doi:10.4103/tcmj.tcmj_117_24
izydorczak, M., Oumov, M., Udhwani, M. V., Fostok, F., Coronas‐Samano, G., Sanganahalli, B. G., Hermán, P., Hyder, F., & Verhagen, J. V. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.04.20.649712
Sandhu, J. K., Thakur, K., Cai, D., Péladeau, C. L., Hewitt, M., & Ghadban, W. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-22300-6.00055-3 · Cited by 1
Amyloid- and Tau-Targeted Therapies in Alzheimer’s Disease
Rajic, A. J., Galasko, D. R., & Tuszynski, M. H. (2025) · Springer eBooks · doi:10.1007/978-3-031-89307-0_17
Long-term Dietary Fat Intervention Affects Retinal Health in APOE MicePreprint
Abhyankar, S. D., Luo, Q., Hartman, G. D., Mahajan, N. S., Corson, T. W., Oblak, A. L., Lamb, B. T., & Bhatwadekar, A. D. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.07.30.667671
DeKosky, S. T. (2023) · The Conversation · doi:10.64628/aai.vjjqjtd6p
The Search for Answers: Causes, Risk Factors, and Current Research in Neurodegenerative Disorders
Kajrolkar, A. (2025) · Premier Journal of Neuroscience · doi:10.70389/pjn.100013
Case Study 10: A 51-Year-Old Man With Psychosis, Decline in Self-Care, and Cognitive Deterioration
Castellana, M. C., Raynor, G., Schildkrout, B., McGinnis, S. M., MacRae, C., Lukacs, M., Miller, M. B., Feany, M. Β., Silbersweig, D., Daffner, K. R., et al. (2025) · Journal of Neuropsychiatry · doi:10.1176/appi.neuropsych.20250048
Novel insight into genetic impacts on neurodegenerative dementia
Xiao, X., Luo, S., Li, J., Jiao, B., & Shen, L. (2025) · Ageing and Neurodegenerative Diseases · doi:10.20517/and.2025.04
Simon, Z. D., McFarland, K. N., Golde, T. E., Chakrabarty, P., & Febo, M. (2025) · Journal of Alzheimer s Disease · doi:10.1177/13872877251378778 · Cited by 2
Genetic Approaches to Neurodegenerative Disease
Takada, L. T., & Yokoyama, J. S. (2025) · Cambridge University Press eBooks · doi:10.1017/9781108985055.009
Gao, X., Jiang, P., Liu, L., Huang, Y., Tan, H., Guo, W., Xie, H., Xing, P., Wang, Q., Peng, S., et al. (2025) · Journal of Affective Disorders · doi:10.1016/j.jad.2025.120788
Shen, M., Tian, J., Devlin, B., & Roeder, K. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2025.12.09.691744
An optogenetic assay of Drosophila larval motor neuron performance in vivo
Arab, Y., Bonassi, G. G., Wilson, M. N., & Macleod, G. T. (2025) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2025.110661
Additional file 1 of Transcriptomic profiling of sporadic Alzheimer’s disease patients
Caldwell, A. B., Anantharaman, B. G., Ramachandran, S., Nguyen, P., Liu, Q., Trinh, I., Galasko, D. R., Desplats, P., Wagner, S. L., & Subramaniam, S. (2022) · Figshare · doi:10.6084/m9.figshare.21321394
Li, Q. S., Sun, Y., & Wang, T. (2020) · Figshare · doi:10.6084/m9.figshare.13107633
Tarozzi, M., Bartoletti‐Stella, A., Dall’Olio, D., Matteuzzi, T., Baiardi, S., Parchi, P., Castellani, G., & Capellari, S. (2022) · Figshare · doi:10.6084/m9.figshare.19159108
Rahman, M. R., Yang, Y., Gratten, J., Anggono, V., & Widagdo, J. (2025) · OMICS A Journal of Integrative Biology · doi:10.1177/15578100251408263
Lee, H.-J., Im, H., Yoon, B., Shim, Y., Won, D., & Lee, J. H. (2026) · Journal of Alzheimer s Disease Reports · doi:10.1177/25424823261419068
Villegas-Llerena, C., Paredes-Moscosso, S. R., Guevara, M. L., Obispo, D., Custodio, N., Montesinos, R., Parodi, J. F., Flores-Flores, O., Hardy, J., & Fujita, R. (2026) · Frontiers in Neuroscience · doi:10.3389/fnins.2025.1724380
Huang, L., Zhang, J., Zhang, S., Lan, Y., Zhang, Q., & Zhang, Y. (2026) · Journal of Alzheimer s Disease · doi:10.1177/13872877251413707
Chen, L., Sun, H., Fang, M.-J., Cheng, N., & Xu, Y. (2026) · International Journal of Surgery · doi:10.1097/js9.0000000000005020
Ramirez, G., Hernandez, D., Teal, A., Chellaganapathy, L., Pianeta, R., Segvich, D. M., Wallace, J. M., & Plotkin, L. I. (2026) · Research Square · doi:10.21203/rs.3.rs-9076483/v1
Park, J. H., Yu, J., Lucey, B. P., & Brubaker, D. K. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.03.21.713391
Hanbouch, L. (2017) · theses.fr (ABES) · doi:10.70675/c4d2c894zf69dz4ae4z9ab1zf4135d0efa12
Molecular mechanisms of action of MT-MMPs involved in the pathogenesis of Alzheimer’s disease
García‐González, L. (2020) · theses.fr (ABES) · doi:10.70675/a04672c0z1f4az472ezbcd5zbea446eac50c
Rochoy, M. (2019) · theses.fr (ABES) · doi:10.70675/4560bf49z9fd2z42a9z83e6zdd4b8e4e87ea
Implication du fragment C99 dans l’avènement des phénotypes pathologiques de la maladie d’Alzheimer
Bourgeois, A. (2019) · theses.fr (ABES) · doi:10.70675/bb8ccf34zec6cz4bb6z82b4z3030b9cb28f7
Linard, M. (2021) · theses.fr (ABES) · doi:10.70675/792b3731z2670z4aedza18ezcd3259857759
Bergeron, S. (2018) · theses.fr (ABES) · doi:10.70675/36a54739zd120z440bzac6aze1ff3180f9f1
Investigating the physiological function of the amyloid precursor protein in Drosophila melanogaster
Kesisoglou, E. (2020) · theses.fr (ABES) · doi:10.70675/691831c4z5491z4cb9zb88az10456e67b7ce
Développement d’un test sanguin pour le dépistage de la maladie d’Alzheimer
Torres, F. D. (2022) · theses.fr (ABES) · doi:10.70675/afbb97a5z1636z46abz844czb340616aeda1
Metadata
- Authors
- Cacace, R., Sleegers, K., & Van Broeckhoven, C.
- Affiliations
- University of Antwerp (BE)
- Neurodegenerative Brain Diseases group Department of Molecular Genetics VIB Antwerp Belgium
- Venue
- Alzheimer's & Dementia
- Publisher
- Wiley
- Published
- 2016-03-23
- Volume
- 12
- Issue
- 6
- Pages
- 733-748
- ISSN
- 1552-5260 (ISSN-L)
- 1552-5279
- OpenAlex
- W2306696647
- Cited by
- 617
- References
- 167
- Citations by year
- 2026: 34 · 2025: 71 · 2024: 60 · 2023: 90 · 2022: 85 · 2021: 88 · 2020: 61 · 2019: 49 · 2018: 35 · 2017: 32 · 2016: 11
- FWCI
- 4.97
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Alzheimer s & Dementia (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Funders
- Fonds Wetenschappelijk Onderzoek
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
- Keywords
- early-onset Alzheimer's disease, familial Alzheimer's disease
- MeSH terms
- Alzheimer Disease, Apolipoproteins E, Humans, Models, Molecular, Molecular Biology, Mutation, Amyloid beta-Protein Precursor, Presenilin-1, Presenilin-2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
